| 他汀类药物对强化调脂治疗的意义 |
| |
| 引用本文： | 陈妮娜,李广平. 他汀类药物对强化调脂治疗的意义[J]. 中国心血管杂志, 2006, 11(5): 390-392 |
| |
| 作者姓名： | 陈妮娜 李广平 |
| |
| 作者单位： | 天津医科大学第二医院心脏科,天津,300211 |
| |
| 摘 要： | 为提高对高脂血症危险性的认识,减少此类血管事件的危险性,1988年美国国家胆固醇教育计划项目(NCEP)的成人教育组(ATP)颁布了其第一套指南。历尽十余年的发展,循证医学(Evidence-based medicine)业已成熟的今天,2001年NCEP ATPⅢ创立了冠心病(CHD)的等危症及其具体的降脂目标并强调了他汀类药物的降脂治疗的独特贡献,2004年又对NCEP ATPⅢ进行修定建议对高危患者进行降脂治疗。
|
| 关 键 词： | 循证医学 低密度脂蛋白胆固醇脂 他汀类药物 |
| 文章编号： | 1007-5410(2006)05-0390-03 |
| 收稿时间： | 2006-01-26 |
| 修稿时间： | 2006-03-10 |
Benefit of Statins in therapeutic hyperlipidemia |
| |
| CHEN Ni-na,LI Guang-ping. Benefit of Statins in therapeutic hyperlipidemia[J]. Chinese Journal of Cardiovascular Medicine, 2006, 11(5): 390-392 |
| |
| Authors: | CHEN Ni-na LI Guang-ping |
| |
| Affiliation: | Second Hospital of Tianjin Medical University, Tianjin 300211, China |
| |
| Abstract: | In order to focus on the dangerous of hyperlipidemia,reducing the risk of CHD and the relative diseases,National Cholesterol Education Program USA(NCEP) Reports Adult Treatment Panel ATP I was published in 1988.During the following ten years evidence-based medicine have so developed,In 2001,NCEP ATP Ⅲ reported CHD and its risk equivalent,what's more is statins' importance in LDL-C-lowering therapy.In the year 2004 NCEP ATP Ⅲ recommended working hard in the most dangerous patients. |
| |
| Keywords: | Evidence-based medicine Low-density lipoproteins cholesterol Statins |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
